Introduction {#sec0001}
============

Hysterectomy is the second most commonly performed surgery for women of reproductive age, and accounts for over \$5 billion in healthcare costs annually. [@bib0001] The United States spends more per capita on healthcare than any other nation, and approximately twice as much as other high-income countries. [@bib0002] Each year healthcare expenditures in the United States continue to rise. The estimated annual health expenditures among American females ≥14 years of age with gynecologic conditions is 10.5 billion dollars.[@bib0003] This creates an imperative to better understand how patients utilize the healthcare system and factors associated with inefficient usage of the system. Many factors contribute to healthcare expenditures including service utilization, prices of services, changes in disease prevalence, pharmaceutical fees, and changes in population size and age structure. [@bib0004] Differences in service or health care utilization have been associated with changes in surgical wait times.[@bib0005]

In women with gynecologic malignancy, the time period between diagnosis of cancer and definitive surgical treatment is defined as the surgical wait time. Increased surgical wait times can be influenced by numerous factors, such as patient preference or preoperative planning and medical clearances, but importantly can also reflect structural problems within a health care system.[@bib0006] Prior studies have found that surgical treatment delays are associated with worse survival for women with gynecologic malignancies such as uterine cancer. [@bib0006], [@bib0007], [@bib0008] Additionally, surgical delay has also been associated with unplanned emergency admissions. [@bib0009]

For women with benign diseases such as fibroids and abnormal uterine bleeding, hysterectomy is typically performed electively after exhaustion of medical management; in this setting, surgical wait time reflects the time from definitive decision to perform hysterectomy to the time of surgery. In women awaiting prolapse surgery and other non-gynecologic surgery, there is some evidence that patients waiting for elective surgery for benign conditions can also experience negative outcomes including increased discomfort, decreased quality of life and increased anxiety. [@bib0010], [@bib0011], [@bib0012] However, the impact of surgical wait time in women undergoing hysterectomy for benign indications has not previously been examined. Understanding how surgical wait times affect patients and the healthcare system can provide targets to improve quality of care and reduce healthcare costs. Additionally, although our interest in this issue predates the COVID-19 pandemic, understanding the impact of delaying benign surgeries may help in better assessing the effects of the current pandemic. The objective of this study was to determine the impact of surgical wait time on healthcare utilization and surgical outcomes in women undergoing hysterectomy for benign gynecologic indications. We hypothesized that surgical wait time \>30 days is associated with increased healthcare utilization.

Methods {#sec0002}
=======

We conducted a retrospective cohort study of women who had a hysterectomy for benign disease at the Hospital of the University of Pennsylvania (HUP) between January 2012 and February 2018 and who were seen preoperatively in the resident gynecology clinic. Approval from the University of Pennsylvania Institutional Review Board was obtained. We obtained billing records to identify cases performed by the resident gynecology service and used Current Procedural Technology (CPT) codes to identify patients who underwent nonlaparoscopic abdominal hysterectomy (CPT codes: 58150, 58152), nonlaparoscopic supracervical hysterectomy (CPT code: 58150), nonlaparoscopic vaginal hysterectomy (CPT codes: 58260, 58262, 58263, 58267, 58270, 58275, 58280, 58285, 58290, 58291, 58292, 58293, 58294), laparoscopic supracervical hysterectomy (CPT codes: 58541, 58542, 58543, 58544), laparoscopic-assisted vaginal hysterectomy (CPT codes: 58550, 58552, 58553, 58554) and total laparoscopic hysterectomy (CPT codes: 58570, 58571, 58572, 58573).[@bib0013] Robotic-assisted laparoscopic cases were included in the appropriate laparoscopic categories.

Women were included in the study if there was documentation of a preoperative visit in the resident gynecology clinic, the Helen O. Dickens Center for Women, and the hysterectomy was performed at the Hospital of the University of Pennsylvania under the care of the resident benign gynecology service. We excluded patients who were incorrectly identified by CPT codes and did not actually have a hysterectomy, were referred outside of the resident clinic for surgery, had a hysterectomy as part of an inpatient admission without a preoperative visit, or who had a preoperative diagnosis of gynecologic malignancy. Standard practice in the resident gynecology clinic is for a patient to attend a preoperative clinic appointment once decision for surgery has been made. At this visit, the patient discusses the intended surgery with a provider and meets with the surgery scheduler to confirm a surgery date within 30 days of their appointment. The patient is expected to receive at least 1 preoperative phone call from the chief resident on the gynecology service prior to surgery. If the patient does not have surgery within 30 days, another visit is made in preoperative clinic prior to the surgery.

Study data were collected and managed using REDCap electronic data capture tools hosted at The University of Pennsylvania.[@bib0014] REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies. The electronic medical record was reviewed for each patient including outpatient records, operative notes, inpatient records, discharge summaries and pathology reports. The following demographic and medical history were abstracted: age, race, insurance type, body mass index (BMI), alcohol use, tobacco use, drug use, history of psychiatric diagnoses, history of hypertension (HTN), history of comorbid medical conditions as defined by the Charlson Comorbididty Index. The following perioperative data were abstracted: date of first preoperative visit, date of surgery, preoperative hemoglobin, American Society of Anesthesiologists (ASA) physical status score, surgical approach (defined as abdominal, total laparoscopic, laparoscopic-assisted vaginal, vaginal or robotic), preoperative use of leuprolide acetate injection, preoperative use of hormonal medications, use of blood and intravenous iron transfusions preoperatively, estimated blood loss, intraoperative complications, length of stay, postoperative complications, uterine weight and 30-day readmission. The following interim healthcare utilization data were collected: number of preoperative visits, number of phone encounters, number of My Penn Medicine messages (MPMs, a secure electronic messaging system), number of office visits (other than preoperative visits), and number of emergency department (ED) visits within the University of Pennsylvania Health System that were related to the indication for surgery or surgery procedure.

Women were divided into two groups: women with surgical wait time \>30 days and women with surgical wait time ≤30 days. The 30-day timeframe was set based on the Centers for Medicare & Medicaid Services (CMS) conditions of participation that require a surgical history and physical to be documented in the patient chart within 30 days of surgery. [@bib0015] Our primary outcome was health care utilization which was defined by the number of patient interactions (phone calls, MPMs, ER and office visits) with the healthcare system from the time of the initial preoperative visit until day of surgery. Each discrete interaction was tabulated as 1 healthcare utilization. For the analysis, healthcare utilization was dichotomized as 0-3 vs 4 or more utilizations. We defined increased healthcare utilization as 4 or more utilizations as we would expect each patient to receive at least 1 preoperative phone call prior to surgery. Our secondary outcomes were rate of intraoperative complications (including estimated blood loss (EBL) \>1 liter, need for intraoperative transfusion, intraoperative visceral or vascular injury), length of hospital stay, readmissions and postoperative complications (including reoperation within 30 days of initial surgery, unplanned intensive care unit transfer, urinary tract infection, pneumonia, venous thromboembolism, superficial surgical site infection, wound dehiscence or separation, postoperative blood transfusion, fever, vesicovaginal fistula formation, renal insufficiency or failure, cerebrovascular accident or death).

Pearson χ^2^ was used to compare categorical variables. Student\'s *t*-test, or Wilcoxon rank sum tests were used to compare continuous variables, where appropriate. Multivariable logistic regression models were performed to assess associations between surgical wait time and healthcare utilization and perioperative outcomes while controlling for confounders. Factors suspected to be associated with increased healthcare utilization and any baseline characteristics significantly different between the two groups were included in our model as potential confounders. Our power calculation estimated that with 277 patients we would have 80% power to detect a risk ratio of 1.8 or higher in women with \>30 day wait time compared to those with ≤30 day wait time with statistical significance at a P value \< 0.05. Statistical analysis was performed using STATA version 14.2 (Stata Corp, College Station, TX).

Results {#sec0003}
=======

A total of 292 women underwent a hysterectomy during the study period; 13 women did not obtain preoperative care in the resident clinic and 2 women were diagnosed with a malignancy, thus leaving 277 women that met our inclusion criteria and were included in the analyses ([Figure 1](#fig0001){ref-type="fig"} ). Of those, 106/277 (38.3%) women were in the surgical wait time \>30 days group (median time to surgery: 47 days, interquartile range of 34-68 days) and 171/277 (61.7%) were in the surgical wait time ≤30 days group (median time to surgery: 19 days, interquartile range of 12-26 days). Most women were in their 5^th^ decade of life, African American and insured under Medicaid. The groups did not differ by comorbid conditions, preoperative hemoglobin, history of psychiatric diagnoses or rates of alcohol, tobacco or substance use ([Table 1](#tbl0001){ref-type="table"} ). Use of leuprolide acetate injection preoperatively was more common in the \>30 days group (p\<.01) ([Table 1](#tbl0001){ref-type="table"}). The benign indications for surgery included fibroids, abnormal uterine bleeding (AUB), adenomyosis, endometriosis, chronic pelvic pain, endometrial hyperplasia, cervical dysplasia and pelvic organ prolapse and were not significantly different between the two groups ([Table 2](#tbl0002){ref-type="table"} ). In the \>30 days group, the reason for longer surgical wait time was not explicitly documented for most women (58/106, 54.7%). Of those in which the reason for a \>30 day wait time was documented, the reasons included: need for medical clearance (n=18), optimization of anemia (n=13), patient preference (n=9), operating room scheduling (n=4), active drug use (n=2), financial concerns (n=1), and patient work schedule (n=1).Figure 1Study population flowchartFlow diagram of subject eligibility assessment and cohort assignment.\*Patient did not attend preoperative visit in the outpatient clinic.Figure 1Table 1Patient Demographic and Preoperative CharacteristicsTable 1Wait Time[\*](#tb1fn1){ref-type="table-fn"}Total, n = 277\>30 d, n = 106≤30 d, n = 171p-value[†](#tb1fn2){ref-type="table-fn"}Time to surgery, days, median (IQR)26 (19-40)47 (34-68)19 (12-26)0.0001Age, mean (±SD)44.4 (7.7)44.4 (7.0)44.3 (8.2)0.948Race, n (%)0.653 African American256 (92)97 (92)159 (93) Other21 (8)9 (8)12 (7)Insurance, n (%)0.357 Private62 (22)24 (23)38 (22) Medicaid175 (63)72 (68)103 (60) Other40 (14)10 (9)21 (18)BMI, n (%)0.914 \<3093 (34)36 (34)57 (33) 30+184 (66)70 (66)114 (67)Alcohol Use, n (%)0.713 No145 (52)54 (51)91 (53) Yes132 (48)52 (49)80 (47)Tobacco Use, n (%)0.957 No185 (67)71 (67)114 (67) Yes92 (33)35 (33)57 (33)Drug Use, n (%)0.236 No229 (83)84 (79)145 (85) Yes48 (17)22 (21)26 (15)HTN, n (%)0.173 No158 (57)55 (52)103 (60) Yes119 (43)51 (48)68 (40)Asthma, n (%)0.741 No206 (74)80 (75)126 (74) Yes71 (26)26 (25)45 (26)Psych, n (%)0.532 No166 (60)66 (62)100 (58) Yes111 (40)40 (38)71 (42)Charlson Comorbidity Index, n (%)0.65 0143 (52)53 (50)90 (53) 189 (32)37 (35)52 (30) 227 (10)8 (8)19 (11) 3+18 (7)8 (8)10 (6)Preoperative HGB, g/dL (%) \<71 (0)1 (1)0 (0)0.518 7-9.960 (22)22 (21)38 (22) ≥10216 (78)83 (78)133(62)Lupron, n (%)23 (8)18 (17)5 (3)\<0.0001Hormone Therapy35 (13)17 (16)18 (11)0.18Preoperative blood transfusion, n (%)15 (5)9 (8)6 (4)0.075Preoperative narcotics, n (5)16 (6)7 (7)9 (5)0.642Preoperative IV Fe, n (%)26 (9)12 (11)14 (8)0.385[^1][^2]Table 2Preoperative Diagnoses[\*](#tb2fn1){ref-type="table-fn"}Table 2IndicationWait time \>30 dWait time ≤30 dFibroids77112AUB76122Adenomyosis2352Endometriosis36Chronic Pelvic Pain4069Endometrial Hyperplasia34Cervical Dysplasia915Pelvic Organ Prolapse10[^3]

There was a statistically significant difference in healthcare utilization between the two groups ([Table 3](#tbl0003){ref-type="table"} ). Women in the \>30 days group were 5.5 times more likely to have increased healthcare utilization (95% CI 3.27-9.41). After controlling for leuprolide use, women in the \>30 days group remained significantly more likely to have increased healthcare utilization (OR 5.09, 95% CI 2.97-8.73). Other covariates including age, diagnosis of HTN, BMI, Charlson Comorbidity index score, and diagnosis of pelvic pain were not confounders for healthcare utilization. For each additional day of surgical wait time, the odds of reaching 4 or more utilizations increased by 3% (OR 1.03, 95% CI 1.02-1.04). The most commonly used mode of healthcare utilization was via telephone. The surgical wait time \>30 days group accounted for 63.5% (641/1010) of the phone calls with an average of 6.73 ± 7.82 calls per patient and the surgical wait time ≤30 days group accounted for 36.5% (369/1010) with an average of 2.32 ± 2.79 calls per patient (p\<0.001). The most common themes of the telephone calls included discussion of details of the surgical procedure (n = 309, 31%), medical clearance (n = 220, 22%), scheduling (n = 196, 19%), and medication management (n = 107, 11%) ([Table 4](#tbl0004){ref-type="table"} ). We defined administrative calls as those related to scheduling and paperwork (e.g. Family Leave and Medical Act forms). When administrative calls were excluded and after controlling for leuprolide use, the \>30 days group still had increased healthcare utilization (OR 3.91, 95% CI 2.20-6.92). This increased utilization remained when expanding administrative calls to include scheduling, paperwork and medical clearance themes (OR 3.52, 95% CI 1.85-6.70).Table 3Healthcare UtilizationTable 3Wait time\>30 d, n = 106≤30 d, n = 171p-value[\*](#tb3fn1){ref-type="table-fn"}**Phone calls**Provider Initiated, median (IQR)3 (2-6)1 (1-2)0.0001Patient Initiated, median (IQR)1 (0-3)0 (0-1)0.0001Number of calls, n (%)\<0.0001 04 (4)34 (20) 116 (15)61 (36) 2+86 (81)76 (44)**My Penn Medicine Messages**Number of messages, n (%)0.241 092 (87)156 (91) 1+14 (13)15 (9)**Visits**Number of visits, n (%)\<0.0001 089 (84)168 (98) 1+17 (16)3 (2)**Healthcare Utilizations, n (%)**\<0.0001 0-337 (35)128 (75) 4+69 (65)43 (25)[^4]Table 4Reasons for Phone CallsTable 4Wait timeReason for Call, n (%)Total, n = 1010\>30d, n = 641≤30d, n = 369Surgery309 (31)153 (24)156 (42)Medication107 (11)70 (11)37 (10)Symptom77 (8)62 (10)15 (4)Paperwork67 (7)31 (5)36 (10)Medical Clearance220 (22)152 (24)68 (18)Scheduling196 (19)155 (24)41 (11)Not documented34 (3)18 (3)16 (4)

Secondary outcomes are outlined in [Table 5](#tbl0005){ref-type="table"} . There was no statistically significant difference in the rate of perioperative complications or length of hospital stay between the two groups. The overall 30-day readmission rate for the cohort was 8% and women in the \>30 days group were 2.85 times more likely to be readmitted than women in the ≤30 days group (95% CI 1.14-7.12). After controlling for hypertension as a potential confounder, the association persisted and women in the \>30 days group were 3.22 times more likely to be readmitted (95% CI 1.27-8.19). No other covariates (age, BMI, Charlson Comorbidity Index score, insurance carrier, perioperative complications, EBL, surgical approach) were significant confounders. Readmission indications are listed in [Table 6](#tbl0006){ref-type="table"} . While there were no readmissions among women who underwent laparoscopic or robotic hysterectomy, the remaining were distributed between abdominal (9) and vaginal (12) hysterectomies (data not shown).Table 5Perioperative OutcomesTable 5Wait time\>30d, n = 106≤30d, n = 171p-value[\*](#tb5fn1){ref-type="table-fn"}**Intraoperative Data**ASA, n (%)0.252 14 (4)6 (4) 263 (59)118 (69) 339 (37)47 (69)Approach, n (%)0.441 Abdominal56 (53)75 (44) TLH8 (8)17 (10) LAVH18 (17)33 (19) TVH24 (23)43 (25) Robotic0 (0)3 (1.8)EBL, n (%)0.514 \<100094 (89)147 (86) 1000+12 (11)24 (14)Intra-operative Complications, n (%)9 (8)19 (11)0.482Intra-operative Transfusion, n (%)6 (6)7 (4)0.549**Postoperative Data**Length of Hospital Stay, days, median (IQR)2 (1-3)2 (1-3)0.122Post-operative Complications, n (%)28 (26)32 (19)0.13Readmission, n (%)13 (12)8 (5)0.02Uterine weight, g, median (IQR)298.7 (748.9-153.5)251 (553.8-138.5)0.216[^5]Table 6Readmission IndicationsTable 6Readmission indication[\*](#tb6fn1){ref-type="table-fn"}, n (%)Wait Time\>30d (n = 13)≤30d (n = 8)Surgical site infection4 (31)3 (38)Gastrointestinal\
Small bowel obstruction\
Ileus\
Nausea/vomiting5 (38)\
2 (15)\
2 (15)\
1 (8)0 (0)Venous\
thromboembolism1 (8)1 (13)Nonsurgical site infection0 (0)2 (25)Cuff dehiscence0 (0)1 (13)Noninfectious wound complication1 (8)0 (0)Pain1 (8)0 (0)Vaginal bleeding0 (0)1 (13)Other1 (8)0 (0)[^6]

Twelve women had both a surgical wait time \>30 days and a readmission. Most of these women did not have clear documentation of the reason for delay to surgery (n = 5) or had a delay due to need for medical clearance (n = 3). Other reasons for delay in this readmission group for the remaining 5 patients included a positive drug screen on the day of surgery (n=1), surgical coordination with plastic surgery for a joint procedure (n=1), anemia (n=1), use of leuprolide acetate preoperatively (n=1), and inactivation of insurance (n=1).

Discussion {#sec0004}
==========

In our study of women undergoing hysterectomy for benign indications, increased surgical wait time was associated with increased healthcare utilization. Women with wait times \>30 days had increased telephone calls and visits between their preoperative visit and surgery date. Additionally, while women with wait times \>30 days did not have an increased rate of perioperative complications, they were 3.22 times more likely to be readmitted following their hysterectomy than women with surgical wait time ≤30 days.

Preoperative healthcare utilization has been shown to be a driver of readmission in surgical patients.[@bib0016] ^,^ [@bib0017] Our data suggests that increased surgical wait times in women awaiting hysterectomy for benign indications have a significant impact on how healthcare is utilized and may be a marker of healthcare quality; thus, a deeper understanding of the factors that contribute to this waiting time is warranted.

In our study, we found that women planning hysterectomy for benign indications with surgical wait times \>30 days have an increased level of healthcare utilization. A study by Walker et al. examined pain-related healthcare utilization among Canadian women awaiting gynecologic surgery. The authors found that approximately one-third of participants experienced unpleasant symptoms (mental distress, pain interference with daily activities, moderate to severe pain intensity) during the preoperative period and the average number of pain-related visits during the year preceding surgery was 3.5 visits per person.[@bib0018] These findings underscore the additional burden on the health system when preventable delays occur. If the women underwent their planned surgery in a timely manner, the additional health care utilization would have been avoided leading to decreased expenditures, and greater capacity to care for other patients waiting to be seen. Thus, measures that reduce wait times may reduce barriers to care.

The impact of surgical wait time on clinical outcomes for women awaiting hysterectomy for benign indications has not been well studied. In our study, we did not find a significant difference in perioperative complications between the two groups. Interestingly, however, we found that women with wait times \>30 days were more likely to call about their symptoms (10% vs 4%) during the intervening period, suggesting that women with longer wait times were more bothered by their symptoms and seeking relief during the interim. In some respects this is not surprising as utilization may be a function of time; however, some themes from the patient phone calls reflect areas where improvement in perioperative patient navigation can be useful. Thus, although increased wait times for benign gynecologic diagnoses may not impact surgical outcomes, there may be significant impact on patients' quality of life (QOL). This finding is consistent with several studies that have assessed the impact of waiting for elective surgery on patient well being as well as the well-established improvement in quality of life that occurs after hysterectomy.[@bib0010] ^,^ [@bib0012] ^,^ [@bib0019] In a prospective, cross-sectional study of women\'s health-related QOL, Leong et al. found women experienced poor emotional role functioning and had negative impacts on mental health while awaiting surgery for pelvic organ prolapse. [@bib0011] In a study that examined QOL among women who underwent hysterectomy, improvements were noted in symptom severity, and 8 QOL domains (concern, activities, energy/mood, control, self-consciousness, and sexual function) at 1-year compared to baseline. [@bib0020] Taken together, these findings suggest that increased surgical wait times prior to hysterectomy for benign indications may adversely impact patient well-being and should be minimized, always taking into account patient safety and optimizing any comorbid medical conditions where appropriate.

While there were no significant demographic differences between the two groups, it is important to note that our study population is predominantly African American and insured under Medicaid. A national cross-sectional study describing patterns of ambulatory care use for gynecologic disorders found an association between younger age, black race, Medicaid insurance, and lower household income and increased health care utilization including emergency department and hospital outpatient department visits.[@bib0021] These associations underscore the need for continued improvement in patient access, quality of care and education about gynecologic disorders in vulnerable populations. In our study, the primary method of healthcare utilization was via telephone calls. The most common reasons for these calls were: discussion of the surgery, preoperative workup/medical clearance and scheduling. In contrast, in a prospective analysis of phone calls among patients scheduled for total thyroidectomy, the most common reasons for calls were preoperative workup, medications and insurance/work-related.[@bib0022] In contrast to our rate of 31%, only 2% of phone calls in their study were related to questions about the surgery. While the difference in reasons for telephone calls between our study and theirs may be related to surgery type, this contrast may reflect differences in patient demographics as their population had a lower proportion (18%) insured under Medicaid. These findings underscore the impact of demographic factors on health care utilization inefficiencies and suggest that improvement in health literacy and patient-centered education about their surgery may decrease redundant health care utilization in vulnerable populations.

The 30-day unplanned readmission rate of 8% in our retrospective cohort is higher than the 2-3% rate that has been reported in the literature and may reflect the poor social determinants of health within our population. [@bib0023], [@bib0024], [@bib0025] Significantly, we found an increased likelihood of readmission for women in the group with longer surgical wait time. For most of the women with both wait time \>30 days and readmission, the reasons for the increased wait times were not clearly identified from retrospective chart review; however, in 3 three of the 12 women who were readmitted, the longer surgical wait time was attributed to need for medical clearance, which may reflect patient comorbidities more than insufficient or inefficient healthcare access. Further studies will need to examine this association and investigate the reason for the relationship between surgical wait time and risk of readmission.

Strengths and Limitations {#sec0005}
=========================

Our study has several strengths. We included a large sample of subjects who had a hysterectomy for benign indications. Data was abstracted directly from a comprehensive electronic medical record, and provides accurate and chronological information for each subject. In an attempt to capture the true impact of the surgical wait time, a comprehensive sample of healthcare utilization methods was included in the analysis.

The study also has some limitations. The retrospective study design imposes a reliance on accurate provider documentation and limits the ability to discern the reasons for surgical wait times, a weakness that could be mitigated by using a prospective study design. There are likely a lot of nuances in the reasons for prolonged surgical wait time and better documentation of these reasons would significantly aid the conclusions we could draw from this study. Nonetheless, our findings are a first step in exploring the impact of delay and suggest that a "benign" indication for hysterectomy does not suggest a lack of urgency. Our data abstraction was limited to the electronic medical record used within one health system, so we are unable to capture interim healthcare utilization at outside institutions. However, given that our clinic and health system is a safety net for many of the women in the surrounding community, we likely captured an accurate depiction of their healthcare utilization. Our cohort included a population of urban and predominantly African American women from a single institution attending a resident clinic. While this may limit the generalizability of our findings, excluding patients from other clinics was intentional, as the patient population served by the resident clinic represents a community that likely faces greater impact from social determinants of health; thus, has the potential to gain much from improvements in the perioperative process. Finally, we examined utilization during the interval from initial preoperative visit to surgery based on the practice patterns at our institution. It is possible that we did not capture the impact of the entire waiting period as a woman may have begun discussion about hysterectomy with her provider for some time prior to referral to the preoperative clinic.

Conclusion {#sec0006}
==========

Longer surgical wait times for benign hysterectomy are associated with increased healthcare utilization in the interim. While patients who experience increased wait times do not have worse surgical outcomes, there may be a significant impact on quality of life. These findings have particular relevance in the current setting of a global pandemic that has required postponement of elective surgeries in certain areas. Further research is needed to better characterize the surgical wait time in women undergoing hysterectomy for benign indications in order to improve efficiency in healthcare utilization and most importantly, to improve the quality of care we provide to our patients.
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[^1]: Wait time in days

[^2]: Pearson chi-square, Student\'s T-test, Kruskall-Wallis where appropriate.

[^3]: More than one preoperative diagnosis was documented for each patient, where applicable. No significant differences between groups.

[^4]: Pearson chi-square or Kruskall-Wallis where appropriate.

[^5]: Pearson chi-square or Kruskall-Wallis where appropriate

[^6]: No statistically significant differences between wait time \>30d and wait time ≤30d, p = 0.121
